Local Production

Følg

Egypt’s Ministry of Health and Population announced that the state-owned Holding Company for Biological Products and Vaccines (VACSERA) hosted a delegation from GenVax Egypt and China’s Minhai to accelerate efforts in localizing production of a key childhood vaccine. The visit aims to fast-track a “gap analysis” plan needed to activate an existing agreement between VACSERA and GenVax Egypt for domestic manufacturing of the pneumococcal conjugate vaccine (PCV13).

Dette nettstedet bruker informasjonskapsler

Vi bruker informasjonskapsler for analyse for å forbedre nettstedet vårt. Les vår personvernerklæring for mer informasjon.
Avvis